A tiny medical device no larger than an eyelash may significantly reduce eye pressure in glaucoma patients and allow some to stop using eye-drop medications, according to year-one clinical trial results for the device. Results of the HYDRUS I clinical trial, which indicate successful control of eye pressure in all study participants, was presented at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology. The Hydrus stent is one of several promising mini-drainage devices now in clinical trials in the United States and other countries. If future trials confirm micro-stents' effectiveness, they could someday help protect millions of glaucoma patients from vision loss or blindness.To see more details visit,
www.medicalnewstoday.com